Alliance Wealth Advisors, LLC /UT

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1893261 Centerville, UT

Position in VRTX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$574,716

-$188,867 QoQ

Shares Held

1,157

-32.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#1,025

of 1,735 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Alliance Wealth Advisors, LLC /UT holds $2,238,891 across 5 Biotechnology names. VRTX ranks #2 (25.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	7,802	$610,662
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,157	$574,716
3	LGND	Ligand Pharmaceuticals Inc	1,772	$560,111
4	REGN	Regeneron Pharmaceuticals, Inc.	442	$275,604
5	KRYS	Krystal Biotech, Inc.	586	$217,798

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$574,716	1,157	-32.3%	Shares	Other	2026-07-23
2026-03-31	$763,583	1,710	-27.0%	Shares	Sole	2026-05-12
2025-12-31	$1,062,675	2,344	-19.1%	Shares	Sole	2026-02-02
2025-09-30	$1,134,972	2,898	+35.1%	Shares	Sole	2025-11-10
2025-06-30	$954,954	2,145	+36.4%	Shares	Sole	2025-08-14
2025-03-31	$762,621	1,573	+68.2%	Shares	Sole	2025-05-13
2024-12-31	$376,524	935	—	Shares	Sole	2025-01-24
No filing history on record for this holder in this stock.